Shujing Ma

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Shanghai Public Health Clinical Center(Current)

Guiyang Medical University

Shujing Ma is an author at Shanghai Public Health Clinical Center specializing in dose escalation, human immunodeficiency virus pharmacotherapy, and antiviral therapy de-escalation.

Publications per year

2023–2023

Publications

Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study

Lin Gan, Xiaoxin Xie, Yanhua Fu et al. · Infectious Diseases and Therapy · 2023 · 18 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Comparison of dolutegravir+Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-naïve patients infected with HIV: preliminary results from clinical practice

Lin Gan, Xiaoxin Xie, Yanhua Fu et al. · Expert Review of Anti-infective Therapy · 2023 · 14 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

1–2 of 2